For the quarter ending 2025-09-30, KZR made $12,741K in revenue. -$11,227K in net income. Net profit margin of -88.12%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Research and development | 6,914 | 9,583 | 16,500 | 16,242 |
| General and administrative | 4,801 | 5,016 | 5,896 | 5,706 |
| Restructuring and impairment charges | 0 | 0 | 368 | - |
| Total operating expenses | 11,715 | 14,599 | 22,886 | 21,948 |
| Loss from operations | -11,715 | -14,599 | -22,886 | -21,948 |
| Interest income | 1,026 | 1,197 | 2,116 | 2,038 |
| Interest expense | - | 302 | 398 | 403 |
| Other expenses | 538 | - | - | - |
| Net loss | -11,227 | -13,704 | -21,141 | -20,313 |
| Net loss per common share, basic (in dollars per share) | -1.53 | -1.87 | -2.903 | -2.78 |
| Net loss per common share, diluted (in dollars per share) | -1.53 | -1.87 | -2.903 | -2.78 |
| Weighted-average shares used to compute net loss per common share, basic (in shares) | 7,323,106 | 7,311,032 | -1,992.333 | 7,296,222 |
| Weighted-average shares used to compute net loss per common share, diluted (in shares) | 7,323,106 | 7,311,032 | -1,992.333 | 7,296,222 |
Kezar Life Sciences, Inc. (KZR)
Kezar Life Sciences, Inc. (KZR)